Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumor in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Market Drivers
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost the global cancer diagnostic market growth. For instance, according to WHO (World Health Organization) cancer is the foremost cause of mortality across the world, which holding account around 9.6 million deaths in 2018. Furthermore, continuous growth of the healthcare and diagnostics sector will positively contribute the market growth during this forecast period. Also, rise in collaborative and independent government as well as private sector initiatives will drive the market growth. Moreover, increase in technological advancements in target disease screening tests will propel the market growth.
Market Restraints
However, high capital investments and low benefit cost ratio for biomarkers is the major challenging factor which is expected to hinder the global cancer diagnostics market growth. Furthermore, high cost of diagnostic imaging systems will hamper the market growth during this analysis period.
Market Segmentation
Global Cancer Diagnostics Market is segmented into diagnostic type such as Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, and Others. Further, market is segmented into application such as Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Pancreatic Cancer, and Others.
Also, Global Cancer Diagnostics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
Market Key Players
Various key players are discussed in this report such as Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Siemens Healthcare, and C.R. Bard, Inc.
Market Taxonomy
By Diagnostic Type
By Application
By Region
Market Drivers
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost the global cancer diagnostic market growth. For instance, according to WHO (World Health Organization) cancer is the foremost cause of mortality across the world, which holding account around 9.6 million deaths in 2018. Furthermore, continuous growth of the healthcare and diagnostics sector will positively contribute the market growth during this forecast period. Also, rise in collaborative and independent government as well as private sector initiatives will drive the market growth. Moreover, increase in technological advancements in target disease screening tests will propel the market growth.
Market Restraints
However, high capital investments and low benefit cost ratio for biomarkers is the major challenging factor which is expected to hinder the global cancer diagnostics market growth. Furthermore, high cost of diagnostic imaging systems will hamper the market growth during this analysis period.
Market Segmentation
Global Cancer Diagnostics Market is segmented into diagnostic type such as Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, and Others. Further, market is segmented into application such as Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Pancreatic Cancer, and Others.
Also, Global Cancer Diagnostics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
Market Key Players
Various key players are discussed in this report such as Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Siemens Healthcare, and C.R. Bard, Inc.
Market Taxonomy
By Diagnostic Type
- Diagnostic Imaging Tests
- Biopsy and Cytology Tests
- Tumor Biomarkers
- Others
By Application
- Breast Cancer
- Lung Cancer
- Cervical Cancer
- Kidney Cancer
- Pancreatic Cancer
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Contents
1 Introduction
2 Research Methodology
4 Global Cancer Diagnostics Market Outlook
5 Global Cancer Diagnostics Market, By Diagnostic Type
6 Global Cancer Diagnostics Market, By Application
7 Global Cancer Diagnostics Market, By Region
8 North America Cancer Diagnostics Market Analysis and Forecast (2020 – 2027)
9 Europe Cancer Diagnostics Market Analysis and Forecast (2020 – 2027)
10 Asia Pacific Cancer Diagnostics Market Analysis and Forecast (2020 – 2027)
11 Latin America Cancer Diagnostics Market Analysis and Forecast (2020 – 2027)
12 Middle East Cancer Diagnostics Market Analysis and Forecast (2020 – 2027)
13 Competitive Analysis
14 Company Profiles
Companies Mentioned
- Becton
- Dickinson and Company
- GE Healthcare
- Abbott
- Roche
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- Siemens Healthcare
- C.R. Bard Inc
